Conclusions Together, once-weekly 2.4 mg semaglutide reduced all-cause mortality by 19%, CV deaths by 15%, and non-CV deaths by 23% among non-diabetic obese or overweight patients with CV disease
Your doctor will review the risks and benefits of a medication with a boxed warning before prescribing it
Compounded Semaglutide Injectable: All four of these tiers include the medication, online medical visit, medical coaching (doctor-led), and free expedited shipping
Do not run it under hot water
It is specifically contraindicated for individuals with: A personal or family history of medullary thyroid carcinoma (MTC), based on findings of thyroid C-cell tumours in animal studies Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Type 1 diabetes or diabetic ketoacidosis semaglutide is not designed for this purpose Pregnancy, or plans to become pregnant within the next 2 months (semaglutide should be discontinued at least 2 months before attempting conception) Age under 12 years (Wegovy is approved from age 12 only for severe obesity, under specialist supervision) Additional caution is needed for patients with a history of pancreatitis, gallbladder disease, diabetic retinopathy, or significant kidney impairment these patients require closer monitoring throughout treatment
![PSA] Albeit rare Copper peptide](https://preview.redd.it/psa-albeit-rare-copper-peptide-uglies-are-real-and-scary-v0-4gk9u5nac2zc1.jpg?width=3024&format=pjpg&auto=webp&s=8d851d295c6a085a163a72066da8ec296d1859aa)
